title: Introduction: The transition from milestones to innovations.
authors.affiliation: Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.|Editor, Supplement on Cardiovascular Disease, Cleveland Clinic Journal of Medicine, Cleveland, OH, USA.
authors.forename: Maan A
authors.initials: MA
authors.lastname: Fares
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000601:surgery; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D015415:Biomarkers; D018660:Blood Pressure Monitoring, Ambulatory; D002318:Cardiovascular Diseases / Q000628:therapy*; D004059:Diffusion of Innovation; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy; D020521:Stroke / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D015912:Thrombolytic Therapy; D061665:Time-to-Treatment; D065467:Transcatheter Aortic Valve Replacement
chemical_list: D000925:Anticoagulants; D000959:Antihypertensive Agents; D015415:Biomarkers